Package 70518-4446-0

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-4446-0
Digits Only 7051844460
Product NDC 70518-4446
Product ID 70518-4446_471a0808-ac8f-668c-e063-6394a90a22b3
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4446-0)

Marketing

Marketing Status
Marketed Since 2025-08-18
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "471a0808-ac8f-668c-e063-6394a90a22b3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["bcbef1b4-a135-4231-bc65-7d0b335260e8"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4446-0)", "package_ndc": "70518-4446-0", "marketing_start_date": "20250818"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "70518-4446_471a0808-ac8f-668c-e063-6394a90a22b3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-4446", "generic_name": "Bupropion Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20250818", "listing_expiration_date": "20261231"}